DTIL•benzinga•
As Of December 31, 2024, Precision BioSciences Had Approximately $108.5M In Cash, Cash Equivalents, And Restricted Cash, With Expected Cash Runway Into The Second Half Of 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga